Clinical and Translational Radiation Oncology
Papers
278
Papers 388
1 page of 39 pages (388 results)
Newest
#1Rutvij A. Khanolkar (U of C: University of Calgary)
#2Harvey Quon (U of C: University of Calgary)H-Index: 13
Last. Kevin Martell (U of C: University of Calgary)H-Index: 5
view all 0 authors...
Abstract null null Purpose null It has previously been shown that increased wait times for prostatectomy are associated with poorer outcomes in intermediate-risk prostatic carcinoma (PCa). However, the impact of wait times on PCa outcomes following low-dose-rate brachytherapy (LDR-BT) are unknown. null null null Methods and Materials null We retrospectively reviewed 466 intermediate-risk PCa patients that underwent LDR-BT at a single comprehensive cancer center between 2003 and 2016. Wait times ...
Source
#1Ifigenia Vasiliadou (Guy's and St Thomas' NHS Foundation Trust)H-Index: 1
Last. S.A. Bhide (The Royal Marsden NHS Foundation Trust)H-Index: 14
view all 0 authors...
Abstract null null Background null The onset of the COVID-19 pandemic necessitated rapid changes to the practice of head and neck oncology. This survey was conducted to assess the pre-Covid-19 pandemic standard of practice for head and neck oncology patients and the treatment modifications introduced during the Covid-19 pandemic in UK. null null null Methodology null The UK National Cancer Research Institute (NCRI) Head and Neck Clinical Studies Group initiated a multi-centre survey using questi...
Source
#1Charlotte L. Deijen (NKI-AVL: Netherlands Cancer Institute)
#2Gerbert L. Vrijenhoek (NKI-AVL: Netherlands Cancer Institute)
Last. Gerben R. Borst (NKI-AVL: Netherlands Cancer Institute)H-Index: 14
view all 0 authors...
Abstract null null Background null In patients with oligometastatic recurrent prostate cancer, standard treatment is androgen deprivation therapy (ADT). However, ADT has many potential side effects that may result in impaired quality of life. Early identification to select patients suitable for stereotactic ablative radiotherapy (SABR) is of utmost importance to prevent or delay start of ADT and its side effects. Because Prostate-Specific Membrane Antigen-11-Positron Emission Tomography (PSMA-11...
Source
#1H. Barnes (The Royal Marsden NHS Foundation Trust)H-Index: 4
#2S.E. Alexander (The Royal Marsden NHS Foundation Trust)H-Index: 2
Last. Marlies E. Nowee (NKI-AVL: Netherlands Cancer Institute)H-Index: 9
view all 0 authors...
Abstract null null Introduction null With the implementation of new radiotherapy technology, it is imperative that patient experience is investigated alongside efficacy and outcomes. This paper presents the development of a specifically designed validated questionnaire and a first report of international multi-institutional preliminary patient experience of MRI-guided adaptive radiotherapy (MRgART) on the 1.5 T MR-Linac (MRL). null null null Methods null A patient experience questionnaire was de...
Source
#1L.T. Tan (University of Cambridge)H-Index: 4
#2Kari Tanderup (Aarhus University Hospital)H-Index: 49
Last. Umesh Mahantshetty (ACTREC: Tata Memorial Hospital)H-Index: 26
view all 0 authors...
Abstract null null Introduction null In 2020, the ESTRO course on image-guided radiotherapy and chemotherapy in gynaecological cancer was converted into an online version due to the COVID-19 pandemic. This paper describes the change process and evaluates the impact on participants compared with previous live courses. null null null Methods and Materials null The 2019 live course contained 41 hours of educational content, comprising 33 hours of synchronous activities (lectures, interactive activi...
Source
#1Keun Yong Eom (Seoul National University Bundang Hospital)H-Index: 15
Source
Abstract null null Background and purpose null Magnetic resonance guided radiotherapy (MRgRT) has been successfully implemented for several routine clinical applications in adult patients. The purpose of this study is to map the potential benefit of MRgRT on toxicity reduction and outcome in pediatric patients treated with curative intent for primary and metastatic sites. null null null Materials and methods null Between May and August 2020, a survey was distributed among SIOPE- and COG-affiliat...
Source
Abstract null null Aim null To prospectively assess toxicities of curative-intent intensity-modulated conformal radiotherapy (IMRT) in patients with extremity soft tissue sarcomas (ESTS). null null null Methods null Data from 59 consecutive patients with ESTS between 2014 and 2019 were both retrospectively and prospectively analysed. Toxicity data were collected both by confidential mailed survey (39% completed) and medical charts, and graded according to CTCAE v5.0. Normal tissues dosimetric da...
Source
#1T. Willigenburg (UU: Utrecht University)H-Index: 2
#2Marieke J. van Son (UU: Utrecht University)H-Index: 2
Last. Max Peters (UU: Utrecht University)H-Index: 13
view all 0 authors...
Abstract null null Background and purpose null Magnetic resonance-guided focal salvage high-dose-rate brachytherapy (FS-HDR-BT) for radiorecurrent prostate cancer (PCa) shows low toxicity rates. However, biochemical failure (BF) after treatment occurs frequently. We developed two prediction models for BF (Phoenix definition) with the aim of enhancing patient counselling before FS-HDR-BT and during follow-up. null null null Materials and methods null A prospective cohort of 150 radiorecurrent PCa...
Source
Abstract null Objectives null To estimate appropriate dose-volume parameters for avoidance of pneumonitis in use of chemoradiotherapy and durvalumab for treatment of lung cancer. null Materials and methods null Patients with non-small cell lung cancer treated with concurrent chemoradiotherapy followed by durvalumab at 9 centers were enrolled in the study. Three-dimensional radiotherapy, intensity modulated radiotherapy, and proton beam therapy were used. The frequency and severity of pneumonitis...
Source
12345678910
Top fields of study
Cancer
Radiology
Oncology
Nuclear medicine
Radiation therapy
Medicine